ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathwayQi Liu(Harbin Medical University), Shizhu Jin(Harbin Medical University)Cell Death DiscoveryFebruary 8, 202210.1038/s41420-022-00846-4Cited by 25SaveCiteExport RISWatch citationsRelated PapersExosomes Derived from BMMSCs Mitigate the Hepatic Fibrosis via Anti-Pyroptosis Pathway in a Cirrhosis Model|Cells|2022|23